BBIO icon

BridgeBio Pharma
BBIO

Overview Fund Activity

247 hedge funds and large institutions have $6.76B invested in BridgeBio Pharma in 2023 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 89 increasing their positions, 77 reducing their positions, and 26 closing their positions.

Holders
247
Holders Change
+26
Holders Change %
+11.76%
% of All Funds
3.62%
Holding in Top 10
15
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+50%
% of All Funds
0.22%
New
53
Increased
89
Reduced
77
Closed
26
Calls
$110M
Puts
$90.1M
Net Calls
+$20.2M
Net Calls Change
-$12.9M

Top Buyers

1
Lord, Abbett & Co
1
Lord, Abbett & Co
New Jersey
$125M
2
Morgan Stanley
2
Morgan Stanley
New York
$134M
3
Goldman Sachs
3
Goldman Sachs
New York
$132M
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$517M
5
BlackRock
5
BlackRock
New York
$410M

Top Sellers

1
HA
1
HHLR Advisors
Cayman Islands
$56.2M
2
CAM
2
Cormorant Asset Management
Massachusetts
$135M
3
WP
3
Woodline Partners
California
$11.7M
4
CS
4
Credit Suisse
Switzerland
$3.67M
5
D.E. Shaw & Co
5
D.E. Shaw & Co
New York
$37.3M
Name Market Value Shares Shares
Change 		Shares
Change %
KKRC
1
Kohlberg Kravis Roberts & Co
New York
$1.25B 31,060,971 – –
Viking Global Investors
2
Viking Global Investors
Connecticut
$1.01B 25,120,991 – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$517M 12,800,294 +1,524,313 +14%
BlackRock
4
BlackRock
New York
$410M 10,156,773 +906,830 +10%
ACM
5
Aisling Capital Management
New York
$245M 6,068,125 – –
LCM
6
Laurion Capital Management
New York
$212M 5,241,833 -409,206 -7%
State Street
7
State Street
Massachusetts
$205M 5,086,899 +46,485 +0.9%
CAM
8
Cormorant Asset Management
Massachusetts
$135M 3,344,179 -1,318,351 -28%
Morgan Stanley
9
Morgan Stanley
New York
$134M 3,319,564 +1,871,504 +129%
Goldman Sachs
10
Goldman Sachs
New York
$132M 3,266,635 +1,841,478 +129%
Lord, Abbett & Co
11
Lord, Abbett & Co
New Jersey
$125M 3,098,082 +2,303,681 +290%
Pictet Asset Management
12
Pictet Asset Management
Switzerland
$112M 2,767,185 +27,163 +1%
FLSM
13
Frazier Life Sciences Management
California
$110M 2,725,949 – –
Geode Capital Management
14
Geode Capital Management
Massachusetts
$110M 2,714,168 +202,988 +8%
AllianceBernstein
15
AllianceBernstein
Tennessee
$103M 2,557,416 -158,724 -6%
Fidelity Investments
16
Fidelity Investments
Massachusetts
$97.5M 2,414,341 -13,181 -0.5%
SUT
17
SC US (TTGP)
California
$75.1M 1,860,364 – –
PA
18
Perceptive Advisors
New York
$70.6M 1,748,933 – –
Citigroup
19
Citigroup
New York
$62.9M 1,557,231 -30,361 -2%
Wellington Management Group
20
Wellington Management Group
Massachusetts
$60.4M 1,495,114 +75,564 +5%
T. Rowe Price Investment Management
21
T. Rowe Price Investment Management
Maryland
$57.9M 1,435,280 +439,648 +44%
HA
22
HHLR Advisors
Cayman Islands
$56.2M 1,391,240 -1,391,510 -50%
Invesco
23
Invesco
Georgia
$51.4M 1,272,536 +112,383 +10%
Norges Bank
24
Norges Bank
Norway
$46.8M 1,160,342 +664,254 +134%
Northern Trust
25
Northern Trust
Illinois
$46.6M 1,154,972 +1,057 +0.1%
1
2 3 4 5